Published in Br J Cancer on February 01, 1973
Activity of mouse complement. J Immunol (1962) 5.14
Technique for identifying Y chromosomes in human interphase nuclei. Nature (1970) 3.64
The effect of neuraminidase on the fate of transfused lymphocytes. J Exp Med (1969) 2.91
An alteration in tumor histocompatibility induced by neuraminidase. Transplantation (1967) 2.63
DOSE-RESPONSE RELATIONSHIPS FOR AGENTS INHIBITING THE IMMUNE RESPONSE. Immunology (1964) 1.96
Experimental evaluation of potential anticancer agents. XXI. Scheduling of arabinosylcytosine to take advantage of its S-phase specificity against leukemia cells. Cancer Chemother Rep (1967) 1.65
Tumour specific immunogenicity of methylcholanthrene-induced sarcoma cells after incubation in neuraminidase. Br J Cancer (1969) 1.59
The role of sialic acid in antigenic expression: further studies of the Landschütz ascites tumour. Br J Cancer (1968) 1.42
Immunogenicity of L 1210 murine leukaemia cells after treatment with neuraminidase. Nature (1968) 1.31
Combined effects of chemotherapy and immunity against leukemia L1210 in DBA-2 mice. Cancer Res (1969) 1.26
Increase of leukemia L1210 immunogenicity by Vibrio cholerae neuraminidase treatment. Cancer Res (1971) 1.20
Quinacrine fluorescence of variant and abnormal human Y chromosomes. Chromosoma (1971) 1.12
Complement sensitivity of neuraminidase-treated lymphoid cells. Transplantation (1971) 1.01
Further studies on the effect of neuraminidase on tumor cell transplantability. Tissue Antigens (1971) 0.97
Effect of enzymatic removal of cell surface sialic acid on the adherence of Walker 256 tumor cells to mesothelial membrane. Cancer Res (1970) 0.92
Triple sex chromatin, and other sex chromatin anomalies, in tumours of females. Br J Cancer (1967) 0.89
In vitro cytotoxicity of normal serum factor(s) on neuraminidase-treated Ehrlich ascites tumor cells and murine leukemia L 1210 cells. Z Immunitatsforsch Exp Klin Immunol (1972) 0.85
Screening data from the Cancer Chemotherapy National Service Center Screening Laboratories. XXI. Can Res Suppl (1964) 0.82
Y chromosomes and quinacrine fluorescence technique. Br Med J (1970) 0.79
Chromosome abnormalities in polyps and carcinomas of the large bowel. Proc R Soc Med (1970) 0.78
Fluorescence study of interphase nuclei and double Y chromosomes. Hereditas (1971) 0.78
Y-chromatin of interphase cancer cells, a preliminary study. Acta Cytol (1972) 0.78
Evolution from fish to mammals by gene duplication. Hereditas (1968) 3.95
A comparison of the DNA content and chromosome number of fifty human tumours. Br J Cancer (1966) 2.07
Specific chromosome change, i(12p), in testicular tumours? Lancet (1982) 1.52
Mutation of the MXI1 gene in prostate cancer. Nat Genet (1995) 1.42
The comparative DNA content of 19 species of placental mammals, reptiles and birds. Chromosoma (1965) 1.38
Prognostic significance of modal DNA value and other factors in malignant tumours, based on 1465 cases. Br J Cancer (1979) 1.38
Chromosomes of testicular teratomas. Cytogenetics (1966) 1.29
Comparative DNA values and chromosome complements of eight species of fishes. Chromosoma (1966) 1.25
Modal deoxyribonucleic acid value and survival in carcinoma of the breast. Br Med J (1972) 1.19
Modal DNA value and chromosome number in ovarian neoplasia. A clinical and histopathologic assessment. Cancer (1971) 1.16
Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status. Cancer Res (1996) 1.12
i(12p): specific chromosomal marker in seminoma and malignant teratoma of the testis? Cancer Genet Cytogenet (1983) 1.07
A 3-cM commonly deleted region in 6q21 in leukemias and lymphomas delineated by fluorescence in situ hybridization. Genes Chromosomes Cancer (2000) 1.02
Possible differences between the karyotypes of preinvasive lesions and malignant tumours. Br J Cancer (1969) 1.00
Chromosome 1 aberrations in cancer. Cancer Genet Cytogenet (1986) 0.99
Stem-like karyotypes of 4 carcinomas of the cervix uteri. Am J Obstet Gynecol (1967) 0.99
On the diploid state of the fish order Ostariophysi. Chromosoma (1968) 0.99
Break points in chromosome #1 abnormalities of 218 human neoplasms. Cancer Genet Cytogenet (1981) 0.98
Prognostic value of ovarian carcinoma grading methods--a method comparison study. Histopathology (1990) 0.96
Prognostic significance of ploidy level in human tumors. I. Carcinoma of the uterus. J Natl Cancer Inst (1976) 0.95
Loss of heterozygosity on chromosome 17p and mutant p53 in HPV-negative cervical carcinomas. Lancet (1992) 0.95
Lack of reciprocal translocations in carcinomas. Cancer Genet Cytogenet (1986) 0.94
Chromosome study of five cancers of the prostate. Hum Genet (1985) 0.94
High chromosome numbers of seminomata and malignant teratomata of the testis: a review of data on 103 tumours. Br J Cancer (1973) 0.93
Prognostic significance of ploidy level in human tumours. II extra-uterine cancers and summary of data on 1171 tumours. Cytobios (1976) 0.93
Chromosomes 1 in 14 ovarian cancers. Heterochromatin variants and structural changes. Hum Genet (1977) 0.91
Abnormal chromosomes including small metacentrics in 14 ovarian cancers. Cancer Genet Cytogenet (1987) 0.90
Chromosome abnormalities, neoplasia, and autoimmune disease. Lancet (1965) 0.90
Triple sex chromatin, and other sex chromatin anomalies, in tumours of females. Br J Cancer (1967) 0.89
Sex chromatin in female breast cancer. Lancet (1967) 0.87
The use of microspectrophotometry. Obstet Gynecol Surv (1969) 0.87
Nonrandom chromosome changes in carcinoma of the cervix uteri. I. Nine near-diploid tumors. Cancer Genet Cytogenet (1982) 0.86
Prognosis of ovarian carcinomas: prediction by histoquantitative methods. Histopathology (1989) 0.86
Abnormal chromosomes and number 1 heterochromatin variants revealed in C-banded preparations from 13 bladder carcinomas. Cytobios (1977) 0.86
Polyploidization in the fish family Cyprinidae, order Cypriniformes. I. DNA-content and chromosome sets in various species of Cyprinidae. Humangenetik (1969) 0.85
Tumour ploidy, morphometry, histological grading and clinical features in ovarian carcinoma: mutual relations. Anal Cell Pathol (1991) 0.85
Pericentric inversion of chromosome 1: frequency and possible association with cancer. Cytogenet Cell Genet (1977) 0.84
Histological cell type and DNA value in the prognosis of squamous cell cancer of uterine cervix. Br J Cancer (1973) 0.84
Cytogenetic study of ten carcinomas of the bladder: involvement of chromosomes 1 and 11. Cancer Genet Cytogenet (1985) 0.84
The nuclear dna content of lampreys. Experientia (1975) 0.84
Chromosome 1 in cervical carcinoma. Lancet (1977) 0.83
Nonrandom chromosome changes in carcinoma of the cervix uteri. II. Ten tumors in the triploid-tetraploid range. Cancer Genet Cytogenet (1984) 0.82
Premature chromosome condensation in carcinoma of the bladder: presumptive evidence for fusion of normal and malignant cells. Cytogenet Cell Genet (1979) 0.82
Nuclear protrusions in malignant tumours with large abnormal chromosomes: observations on C-banded preparations. Experientia (1979) 0.81
Microchromosomes in holocephalian, chondrostean and holostean fishes. Chromosoma (1969) 0.81
The use of the crushing condenser for photometric and other cytologic studies on histologic sections. Acta Cytol (1971) 0.80
The influence of nuclear size and chromosome complement on prognosis of carcinoma of the cervix. Proc R Soc Med (1966) 0.79
Y chromosomes and quinacrine fluorescence technique. Br Med J (1970) 0.79
A nuclear protrusion in a human tumor associated with an abnormal chromosome. Acta Cytol (1966) 0.79
Evidence for the presence of a large marker chromosome in histological sections of a carcinoma in situ of the cervix uteri. J Obstet Gynaecol Br Commonw (1968) 0.79
Chromosome changes in early gynecologic malignancies. Acta Cytol (1983) 0.79
Chromosome abnormalities in polyps and carcinomas of the large bowel. Proc R Soc Med (1970) 0.78
DNA Content of Human Tumours: Change in Uterine Tumours During Radiotherapy and their Response to Treatment. Br J Cancer (1959) 0.78
Chromosome 10 deletion in carcinoma of the prostate. N Engl J Med (1985) 0.78
Chromosome 1 in 26 carcinomas of the cervix uteri: structural and numerical changes. Cancer (1979) 0.78
Antioncogenes. Lancet (1985) 0.77
Squamous cell carcinomas of the head, neck, and skin. Monoclonal or polyclonal origin? Cancer Genet Cytogenet (1991) 0.77
Consistency of quantitative methods in ovarian tumor histopathology. Int J Gynecol Pathol (1990) 0.77
Use of the mitotic counts for the prognosis and grading of breast cancer. Method evaluation study. Pathol Res Pract (1994) 0.77
Cytophotometric DNA determination correlated to karyotype, particularly in cancer. Anal Quant Cytol Histol (1987) 0.77
A metastatic malignant melanoma with 24 chromosomes. Hum Genet (1981) 0.76
Chromosome analysis of three seminomas. Cancer Genet Cytogenet (1985) 0.76
Specific chromosome change in ovarian cancer. Cancer Genet Cytogenet (1981) 0.76
Chromosome studies on 14 near-diploid carcinomas of the ovary. Eur J Cancer (1974) 0.76
Duplication of the long arm of chromosome 1 in a malignant vaginal tumour. Br J Cancer (1978) 0.76
Heterochromatin polymorphism and human cancer. Cancer Genet Cytogenet (1981) 0.76
Letter: Large Y chromosome found in polymorphs by a C-staining technique. Br Med J (1975) 0.75
Cytogenetic studies of basal cell carcinomas. Cancer Genet Cytogenet (1990) 0.75
Chromosome 1 heteromorphism in patients with malignant disease: a constitutional marker for a high-risk group? Br Med J (1977) 0.75
Chromocentres in polymorphs as interphase markers for chromosomes having increased constitutive heterochromatin. J Med Genet (1974) 0.75
Sex chromatin positive metastatic melanoma in a male with a favourable prognosis. Br J Cancer (1971) 0.75
Gonadal Dysgenesis with Unusual Abnormalities. Arch Dis Child (1965) 0.75
Protruding chromosome arms in histological sections of tumours with large marker chromosomes. Br J Cancer (1968) 0.75
Variable sex chromatin pattern in an early carcinoma of the bladder. J Clin Pathol (1973) 0.75
Clonal chromosome changes including a del(6q) in a possible early lymphoma. Cancer Genet Cytogenet (1996) 0.75
Experimental model. Science (1980) 0.75
Sex chromatin in cervical smears. Acta Cytol (1968) 0.75
Endomitosis in human trophoblast? Hum Genet (1983) 0.75
A high incidence of cells with a condensed (telophase) chromatin pattern in human tumors and carcinoma-in-situ. Acta Cytol (1967) 0.75
Nonrandom chromosome changes in carcinoma of the cervix uteri. Acta Cytol (1982) 0.75
The chromosome number of 'hypochromic' cancer cells. Acta Cytol (1971) 0.75
Ploidy as prognostic determinant in lung cancer. Lancet (1988) 0.75
Chromosome 1 C-band heteromorphisms in patients with carcinoma in situ and invasive carcinoma of the cervix uteri. Aust N Z J Obstet Gynaecol (1983) 0.75
Chromosome and D.N.A. abnormalities in ovarian cystadenomas. Lancet (1970) 0.75
Gene action in fish of tetraploid origin. II. Cellular and biochemical parameters in clupeoid and salmonoid fish. Biochem Genet (1975) 0.75
Cytogenetic observations on a carcinoma of the cervix uteri with double minute chromatin bodies. Eur J Cancer (1980) 0.75
Letter: Nature of nuclear projections in adenocarcinoma of the breast. Lancet (1974) 0.75
Screening for malignancy of the cervix. Lancet (1973) 0.75
High chromosome numbers of testicular germ cell tumors. An update. Cancer Genet Cytogenet (1995) 0.75
Perimodal variation of DNA values of normal and malignant cells. Acta Cytol (1969) 0.75
Mitotic spindle failure in human cancer. Cancer Genet Cytogenet (1992) 0.75
Three or four copies of a dicentric 17q isochromosome in an acute myeloproliferative disorder. Cancer Genet Cytogenet (1981) 0.75
A carcinoma of the cervix uteri with hypodiploid and hypotetraploid stem-lines. Eur J Cancer (1967) 0.75
Chromosome 1 heterochromatin variants and cancer: a reassessment. Cancer Genet Cytogenet (1985) 0.75
Cytogenetic aspects of malignant transformation. Exp Biol Med (1976) 0.75
DNA ploidy of cervical intraepithelial neoplasia (CIN) Cancer Genet Cytogenet (1997) 0.75
Cancer research. Science (1978) 0.75
Lymphomas and dysproteinaemias. Clin Haematol (1980) 0.75
The chromosome complement of the aardvark, Orycteropus afer. Chromosoma (1970) 0.75
Interpretation of changes in the uterine cervix. Lancet (1969) 0.75